Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Wendell Wierenga currently holds 32,637 shares of Dermata Therapeutics, Inc. (DRMA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Wendell Wierenga has been a net seller of DRMA stock. They have purchased $0 and sold $1.6M worth of shares.
Wendell Wierenga's most recent insider trade was on Apr 15, 2026, when they sold 95 shares at $65.37 per share.
Wendell Wierenga serves as Executive at Dermata Therapeutics, Inc. (DRMA). They have executed 11 insider transactions totaling $1.6M over their tenure at the company.
Wendell Wierenga holds the position of Executive at Dermata Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Wendell Wierenga has shown a selling trading pattern, with $0 in total purchases and $1.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Wendell Wierenga was on Dec 22, 2025, when they sold $1.3M worth of CYTK shares. This transaction involved 20,000 shares at $66.14 per share.
Wendell Wierenga currently owns 32,637 shares of Dermata Therapeutics, Inc. (DRMA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Wendell Wierenga's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Wendell Wierenga has 11 Form 4 filings on record as an insider at Dermata Therapeutics, Inc..
Set alerts for Wendell Wierenga and 40,000+ other insiders.